Ultra-sensitive biosensor based on CRISPR-Cas12a and Endo IV coupled DNA hybridization reaction for uracil DNA glycosylase detection and intracellular imaging
Biosensors and Bioelectronics · 2023-04 · 226 · 115118
DOI: 10.1016/j.bios.2023.115118 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2023-04. Verfasst von Kejun Dong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. Hauptthemen laut MEDLINE: Uracil-DNA Glycosidase, Biosensing Techniques. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
As an essential biomarker associated with various diseases, Uracil-DNA Glycosylase (UDG) detection is vital for disease diagnosis, treatment selection, and prognosis assessment. In recent years, the signal amplification effect of the CRISPR-Cas12a trans-cleaved single-stranded DNA probe has provided an available strategy for constructing highly sensitive biosensors. However, its superior trans-cleavage activity has become a "double-edged sword" for building biosensors that can amplify the target signal while also amplifying the leakage signal, causing out of control. Therefore, the construction of structurally simple, extremely low-background, highly sensitive CRISPR-Cas12a-based biosensors is an urgent bottleneck problem in the field. Here, we applied CRISPR-Cas12a with a DNA hybridization reaction to develop a simple, rapid, low background, and highly sensitive method for UDG activity detection. It has no PAM restriction and the detection limit is as low as 2.5 × 10-6 U/mL. As far as we know, this method is one of the most sensitive methods for UDG detection. We also used this system to analyze UDG activity in tumor cells (LOD: 1 cell/uL) and to evaluate the ability to screen for UDG inhibitors. Furthermore, we verified the possibility of intracellular UDG activity imaging by transfecting the biosensors to the cells. We believe this novel sensor has good clinical application prospects and will effectively broaden the application space of CRISPR-Cas12a.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. Electronic address: zhangweidr@hust.edu.cn.
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China; Clinical Research Center of Cancer Immunotherapy of Hubei, Wuhan, 430…
Zitieren
APA
Dong, K., Shu, W., Zhang, J., Cheng, S., Zhang, J., Zhao, R., Hua, T., Zhang, W., & Wang, H. (2023). Ultra-sensitive biosensor based on CRISPR-Cas12a and Endo IV coupled DNA hybridization reaction for uracil DNA glycosylase detection and intracellular imaging. Biosensors and Bioelectronics, 226, 115118. https://doi.org/10.1016/j.bios.2023.115118
Vancouver
Dong K, Shu W, Zhang J, Cheng S, Zhang J, Zhao R, et al. Ultra-sensitive biosensor based on CRISPR-Cas12a and Endo IV coupled DNA hybridization reaction for uracil DNA glycosylase detection and intracellular imaging. Biosensors and Bioelectronics. 2023;226:115118. doi:10.1016/j.bios.2023.115118
BibTeX
@article{Dong2023,
author = {Dong, Kejun and Shu, Wan and Zhang, Jiarui and Cheng, Shuangshuang and Zhang, Jun and Zhao, Rong and Hua, Teng and Zhang, Wei and Wang, Hongbo},
title = {Ultra-sensitive biosensor based on CRISPR-Cas12a and Endo IV coupled DNA hybridization reaction for uracil DNA glycosylase detection and intracellular imaging},
journal = {Biosensors and Bioelectronics},
year = {2023},
volume = {226},
pages = {115118},
doi = {10.1016/j.bios.2023.115118}
}
EUVIMED